Melanoma Vaccine Extends Cancer-Free Survival

Work presented this week at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and also published in the Journal of Clinical Oncology describes results from a phase 2B study evaluating the combination of intismeran, a cancer vaccine, and…